PET-CT Clinical Fellowship
Dana-Farber Cancer Institute is a National Cancer Institute-designated comprehensive cancer center. This clinical fellowship will provide physicians with advanced clinical imaging training in oncology with a focus on PET-CT, novel therapies, and cross-sectional
imaging. Fellows also have the opportunity to participate in various clinical research projects. Major areas of interest include molecular imaging, evaluation of novel therapeutic drugs, and new PET radiopharmaceuticals. The PET-CT Clinical Fellowship
is offered in a 12-month or 3-month track with the latter tracks’ remaining months spent in general cancer imaging, CT, MR and U/S.
Rotation overview
- Depending on the chosen track (general cancer imaging or PET-CT): 80% time will be spent reading cancer imaging studies with our CT, MR, U/S, or PET-CT.
- Approximately 20% of the Fellow's time can be dedicated to research, assuming that a detailed research project outline has been presented and approved by an attending radiologist as the project mentor. Research milestone schedules are clearly articulated
and research progress is closely monitored.
- Four weeks of the CIP Fellowship is designated elective time. Elective time may be spent on approved research projects, or in other radiology disciplines elsewhere.
- On-call responsibilities consist of weekend day coverage.
Eligibility
U.S. applicants must be board eligible or board certified in radiology. Foreign applicants must be ECFMG certified, trained in radiology and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at Dana-Farber is structured
in accordance with fellowship regulations as provided by the Department of Radiology at Brigham and Women's Hospital.
Teaching/conference responsibilities
There is a weekly seminar series designated for Category 1 CME credit, including introductory and modality-based lectures and disease-centric "blocks" thereafter. Other educational activities include a weekly radiology-pathology conference, drug conferences,
and MRI/CT case conferences. These are in addition to continual one-on-one teaching throughout the day.
Fellowship supervision and evaluation
Dana-Farber Imaging Fellows will receive continuous on-site training, teaching, and feedback. Dr. Fiona Fennessy, Director of the Dana-Farber Cancer Imaging Fellowship Program, Dr. Atul Shinagare, Associate Director, Cancer Imaging Fellowship Program, Dr. Heather Jacene, Clinical Director of Nuclear Medicine and Dr. Moritz Kircher, Chair of the Department of Imaging at Dana-Farber, will evaluate the fellow's performance.
Equipment and resources
State of the art equipment includes with two GE Discovery MI PET/CT scanners, and two Siemens Symbia Intevo SPECT/CT scanners. Both PET/CT scanners have 4-rings of digital PET detectors (SiPM) for a 20 cm axial field of view with improved sensitivity and spatial and temporal resolution. All processed images are archived on GE Centricity PACS. Clinical images are housed on an enterprise-wide GE Centricity PACS. There are twenty-four Enterprise PACS/2MP workstations for reviewing images in Radiology and Nuclear Medicine. There are eleven stand-alone Hermes workstations. There are several tools and applications supporting Radiology research projects.
Application procedure
Applicants should send their C.V., personal statement, USMLE scores, and three reference letters (sent directly by the referees) to the address below. Canadian Physicians and Doctors of Osteopathy who are eligible may substitute documents: LMCC/MCCQE
and COMLEX examinations. Other foreign applicants must send ECFMG certification.
Fiona M. Fennessy, MD, PhD, Cancer Imaging Fellowship Program Director
Atul Shinagare, MD, Cancer Imaging Fellowship Associate Director
Dana-Farber Cancer Institute, Department of Imaging (DL101)
450 Brookline Ave.
Boston, MA 02215
Attention: Ashley Watterson
Phone: 617-632-4891
Fax: 617-582-8574
Email:
CancerImagingFellowship@dfci.harvard.edu